SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-071346
Filing Date
2009-04-02
Accepted
2009-04-02 11:24:55
Documents
1
Period of Report
2009-05-20
Effectiveness Date
2009-04-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 543024
  Complete submission text file 0001193125-09-071346.txt   544490
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27570 | Film No.: 09725930
SIC: 8731 Services-Commercial Physical & Biological Research